DRREDDY:NSE
Dr Reddy's Laboratories Ltd
1 208,00 ₹
arrow_upward
+0,42%(+5,00) 1 p
6. okt, 14:42:21 GMT +5:30 · INR
search
Kõik sümbolid
| Sümbol | Hind | Muutus | % muutus |
|---|
insights_autoÜksuse DRREDDY põhistatistika genereerimine…
Ava
1 207,00 ₹
Kõrge
1 212,70 ₹
Madal
1 195,00 ₹
Turu kapit.
1,00 trln
Keskm. maht
1,79 mln
Maht
1,38 mln
Dividend
0,66%
Kvartaalne dividend
2,00 ₹
Dividendikuupäev
10. juuli 2026
Hinna ja tulu suhe
31,24
52 näd kõrgeim
1 414,90 ₹
52 näd madalaim
1 101,00 ₹
Aktsiatulu
38,67 ₹
Käibivad aktsiad
166,06 mln
Töötajate arv
28 tuh
Ava
1 207,00 ₹
Kõrge
1 212,70 ₹
Madal
1 195,00 ₹
Turu kapit.
1,00 trln
Keskm. maht
1,79 mln
Maht
1,38 mln
Dividend
0,66%
Kvartaalne dividend
2,00 ₹
Dividendikuupäev
10. juuli 2026
Hinna ja tulu suhe
31,24
52 näd kõrgeim
1 414,90 ₹
52 näd madalaim
1 101,00 ₹
Aktsiatulu
38,67 ₹
Käibivad aktsiad
166,06 mln
Töötajate arv
28 tuh
Uudised
Veebiallikatest ja uudistepartneritelt
TradingView
·
20 tunni eest
Healthcare shares extend decline for 3rd day; Sun Pharma, Dr. Reddy's fall up to 1%
TipRanks
·
22 tunni eest
Dr. Reddy’s U.S. Subsidiary Hit with Modest IRS Penalty, Assessed as Non‑Material
Profiil
Dr. Reddy's Laboratories Ltd. is an Indian multinational pharmaceutical company based in Hyderabad, with U.S. headquarters in East Brunswick, New Jersey. The company was founded by Kallam Anji Reddy, who previously worked in the mentor institute Indian Drugs and Pharmaceuticals Limited. Dr. Reddy's manufactures and markets a wide range of pharmaceuticals in India and overseas. The company produces over 190 medications, 60 active pharmaceutical ingredients for drug manufacture, diagnostic kits, critical care, and biotechnology.
Dr. Reddy's began as a supplier to Indian drug manufacturers, but it soon started exporting to less-regulated markets that had the advantage of not having to spend time and money on a manufacturing plant that would gain approval from a drug licensing body such as the U.S. Food and Drug Administration. By the early 1990s, the expanded scale and profitability from these unregulated markets enabled the company to begin focusing on getting approval from drug regulators for their formulations and bulk drug manufacturing plants – in more-developed economies. This allowed their movement into regulated markets such as the US and Europe.
By 2007, Dr. Wikipedia
Teave üksuse Dr Reddy's Laboratories Ltd kohta
TegevjuhtErez Israeli
Töötajad27,5 tuh
Asutatud1984
PeakontoridHyderabad, Andhra Pradesh, India
Sektor-
Veebisaitdrreddys.com